News

Longer-term use of the oral blood thinner Xarelto significantly cut the risk of recurrence of potentially life-threatening blood clots with no additional major bleeding compared with…
Read More...

Oxford BioDynamics is participating in a collaboration to identify the biological factors that trigger disease relapses, known as flares, in Rheumatoid Arthritis (RA), entitled the…
Read More...

Threshold Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapies for cancer, and Molecular Templates, Inc., a privately held biopharmaceutical…
Read More...

Acura Pharmaceuticals, Inc. and MainPointe Pharmaceuticals, LLC announced that they have entered into a License Agreement (the "Agreement") to have MainPointe exclusively market NEXAFED…
Read More...

Alkermes plc announced the initiation of a new phase 3 study of ALKS 8700, a novel, oral monomethyl fumarate (MMF) prodrug candidate in development for the treatment of relapsing forms…
Read More...

Israeli biotechnology company Kadimastem, announced that it has been granted a patent from the United States Patent and Trademark Office for its technology in the field of cell based…
Read More...

PTC Therapeutics, Inc. announced it has entered into an asset purchase agreement with Marathon Pharmaceuticals, LLC to acquire all rights to Emflaza™ (deflazacort). Emflaza is the first…
Read More...

Glycyx PharmaVentures Ltd., a biopharma investment and development company founded by Lorin K. Johnson, Ph.D., has agreed to enter into an exclusive license agreement with Valeant…
Read More...

Ferring Pharmaceuticals and Brazil-based Instituto de Ciências Farmacêuticas (ICF) today announced a research collaboration aimed at developing a mucoadhesive rectal delivery system to…
Read More...

Trovagene, Inc., a precision medicine biotechnology company, and Nerviano Medical Sciences, S.r.l., a leading oncology discovery organization, today announced that they have signed a…
Read More...

Life science researchers working across many applications can now benefit from the first-ever web-based pipetting application, developed to enable seamless connectivity with electronic…
Read More...

The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has granted Sanofi’s dupilumab, an investigational treatment for atopic dermatitis (AD), a positive scientific…
Read More...

Pfizer Inc. announced that Zavicefta, a novel combination antibiotic for the treatment of patients with certain confirmed or suspected Gram-negative bacterial infections requiring…
Read More...

Biocept, Inc., a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients,…
Read More...

AMO Pharma Limited, a privately held biopharmaceutical company focusing on debilitating diseases with limited or no treatment options, today announced it has entered a collaboration…
Read More...

Pfizer has launched Zavicefta (ceftazidime/avibactam), a combination antibiotic to treat Gram-negative bacterial infections requiring hospitalization, in the UK and Germany. Pfizer…
Read More...

Mylan N.V. announced that Mylan has agreed to the terms of a global settlement with Genentech, Inc. and F. Hoffmann-La Roche Ltd. in relation to patents for Herceptin® (trastuzumab),…
Read More...

Charles River Laboratories International, Inc., a leading early-stage contract research organization (CRO), today announced that it has extended its longstanding, strategic, integrated…
Read More...

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, and Definiens, the leader in Tissue Phenomics® solutions from biomarker discovery to meaningful…
Read More...

Midatech Pharma, the international specialty pharmaceutical company focused on developing and commercialising products in oncology, is pleased to announce the successful initial…
Read More...